| Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma | New England Journal of Medicine | 2019 | 185 |
| Prevalence, risk factors, and management of asthma in China: a national cross-sectional study | Lancet, The | 2019 | 180 |
| Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial | Lancet, The | 2019 | 105 |
| The Global Initiative for Asthma (GINA): 25 years later | European Respiratory Journal | 2019 | 92 |
| Strategies to Enhance Drug Absorption via Nasal and Pulmonary Routes | Pharmaceutics | 2019 | 87 |
| 2019 ARIA Care pathways for allergen immunotherapy | Allergy: European Journal of Allergy and Clinical Immunology | 2019 | 83 |
| Treatable traits can be identified in a severe asthma registry and predict future exacerbations | Respirology | 2019 | 80 |
| Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology | Journal of Allergy and Clinical Immunology | 2019 | 70 |
| Autophagy Activation in Asthma Airways Remodeling | American Journal of Respiratory Cell and Molecular Biology | 2019 | 70 |
| Community-wide Screening for Tuberculosis in a High-Prevalence Setting | New England Journal of Medicine | 2019 | 58 |
| Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study | Journal of Allergy and Clinical Immunology | 2019 | 57 |
| Associations between daily air quality and hospitalisations for acute exacerbation of chronic obstructive pulmonary disease in Beijing, 2013-17: an ecological analysis | Lancet Planetary Health, The | 2019 | 56 |
| GSDMD is required for effector CD8 T cell responses to lung cancer cells | International Immunopharmacology | 2019 | 54 |
| Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma | Clinical and Translational Allergy | 2019 | 49 |
| Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network | European Respiratory Journal | 2019 | 47 |
| Saturated fatty acids, obesity, and the nucleotide oligomerization domain-like receptor protein 3 (NLRP3) inflammasome in asthmatic patients | Journal of Allergy and Clinical Immunology | 2019 | 47 |
| Restless REM Sleep Impedes Overnight Amygdala Adaptation | Current Biology | 2019 | 46 |
| All-cause mortality and long-term exposure to low level air pollution in the '45 and up study' cohort, Sydney, Australia, 2006-2015 | Environment International | 2019 | 41 |
| Kinetics of the accumulation of group 2 innate lymphoid cells in IL-33-induced and IL-25-induced murine models of asthma: a potential role for the chemokine CXCL16 | Cellular and Molecular Immunology | 2019 | 39 |
| Smart thermosensitive chitosan hydrogel for nasal delivery of ibuprofen to treat neurological disorders | Expert Opinion on Drug Delivery | 2019 | 37 |
| Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study | Clinical and Experimental Allergy | 2019 | 37 |
| Molecular mechanisms of azole resistance in Candida tropicalis isolates causing invasive candidiasis in China | Clinical Microbiology and Infection | 2019 | 36 |
| A systematic literature review and critical appraisal of epidemiological studies on outdoor air pollution and tuberculosis outcomes | Environmental Research | 2019 | 34 |
| Role of Dual-Specificity Phosphatase 1 in Glucocorticoid-Driven Anti-inflammatory Responses | Frontiers in Immunology | 2019 | 32 |
| A sputum 6-gene signature predicts future exacerbations of poorly controlled asthma | Journal of Allergy and Clinical Immunology | 2019 | 31 |
